Markets for immunoagents, probes and molecular diagnostics to grow to $60.3 billion by 2016

The market for immunoagents, probes and molecular diagnostics was $29.6 billion in 2010. This market is projected to be $33.5 billion in 2011 and will increase up to $60.3 billion by 2016 at a compound annual growth rate (CAGR) of 12.5%.

Learn about the major research and development (R&D) initiatives which are leading to the development of new products to improvements in the sensitivities and performance of existing immunoassay products. Company profiles are also included...

Use this report to:

• Gain a detailed analysis of the consumption and future growth potential of immunoagents, gene probes, and molecular diagnostics
• Determine recent technological developments, future industry trends, and emerging business opportunities
• Analyze the underlying influences brought about by rapid developments in diagnostic products, changes in governmental regulations, and the evolving economies of countries such as China, India, the Pacific Rim, Australia, Brazil, Russia, and the Middle East
• Outline the international supply and demand for compounds used in immunoassays and in probes, including gene probes and related chemicals employed in diagnostic tests.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
MARKETS FOR IMMUNOAGENTS, PROBES AND MOLECULAR DIAGNOSTICS, 2009-2016
($ MILLIONS)

Source: BCC Research